Article: Chicago Tribune Inside Health Care Column.

Byline: Bruce Japsen

Jan. 22--Allegations similar to those raised in the federal government's massive case against TAP Pharmaceutical Products Inc. have emerged in a recent indictment of a New Jersey physician who prescribed a rival company's prostate cancer treatment.

A federal grand jury in Wilmington, Del., last week indicted Dr. Saad Antoun on charges of conspiring to receive kickbacks for prescribing the prostate cancer drug Zoladex, made by AstraZeneca, the U.S. attorney's office in Wilmington said.

Lake Forest-based TAP agreed in October to pay a record $875 million settlement and plead guilty to a criminal charge of conspiring with ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!